Related Experiment Videos
Community pharmacy practice in China: past, present and future
Yu Fang1, Shimin Yang, Siting Zhou
1Department of Pharmacy Administration, School of Pharmacy, Health Science Center, Xi'an Jiaotong University, No. 76 Yanta West Road, Xi'an, 710061, People's Republic of China. yufang@mail.xjtu.edu.cn
International Journal of Clinical Pharmacy
|May 11, 2013
Summary
China
Area of Science:
- Pharmacy Practice
- Healthcare Systems
- Pharmaceutical Care
Background:
- China's 2009 healthcare reform emphasized primary care access.
- Community pharmacies and pharmacists were assigned expanded roles in delivering pharmaceutical care.
Purpose of the Study:
- To review the current state of community pharmacy education and practice in China.
- To identify future directions for pharmacy practice in China.
Main Methods:
- Literature search of MEDLINE and International Pharmaceutical Abstracts.
- Cross-referencing of articles and books.
- Inclusion of data from relevant websites.
Main Results:
- China has 388,000 retail pharmacies, with one per 3,532 population.
- While pharmacies offer dispensing and counseling, lack of reimbursement hinders service quality.
- Shortages of qualified pharmacists and training impact pharmaceutical care delivery.
- 25 universities now offer clinical pharmacy degrees to address pharmacist demand.
- Adoption of Good Pharmacy Practice provides a framework for service delivery.
Conclusions:
- Key areas for development include enacting a Pharmacist Law, standardizing pharmaceutical care, workforce development, and establishing reimbursement.
- Despite current underdevelopment, pharmaceutical care is expected to become integral to future pharmacy practice in China, especially in community settings.
Related Concept Videos
01:26Pharmaceutical Poisoning: Potential Scenarios
Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
01:22Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
01:15Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).
01:06Three-Compartment Open Model
The three-compartment open model is a pharmacokinetic model used to describe the distribution and elimination of drugs following extravascular administration. It comprises a central compartment representing the plasma and two peripheral compartments. The highly perfused peripheral compartment represents organs and tissues with a rich blood supply, such as the liver, kidneys, and lungs. The scarcely perfused peripheral compartment represents tissues with lower blood supply, such as adipose...
01:00Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are not...
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...